Related Experiment Video
Updated: Aug 11, 2026

Deacetylation Assays to Unravel the Interplay between Sirtuins (SIRT2) and Specific Protein-substrates
Published on: February 27, 2016
Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation
Yonghua Yang1, Huayan Hou, Edward M Haller
1Department of Pathology, University of South Florida College of Medicine, Drug Discovery and Experimental Therapeutics, H Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
Abstract:
Forkhead box class O (FOXO) proteins are transcription factors that function downstream of the PTEN tumor suppressor and directly control the expression of genes involved in apoptosis, cell cycle progression, and stress responses. In the present study, we show that FOXO1 interacts with four and a half LIM 2 (FHL2) in prostate cancer cells. This interaction occurred in the nucleus and was enhanced by lysophosphatic acid. FHL2 decreased the transcriptional activity of FOXO1 and the expression of known FOXO target genes and inhibited FOXO1-induced apoptosis. Interestingly, SIRT1, a mammalian homolog of yeast Sir2, bound to and deacetylated FOXO1 and inhibited its transcriptional activity. FHL2 enhanced the interaction of FOXO1 and SIRT1 and the deacetylation of FOXO1 by Sirtuin-1 (SIRT1). Overall, our data show that FHL2 inhibits FOXO1 activity in prostate cancer cells by promoting the deacetylation of FOXO1 by SIRT1.
Insights
In prostate cancer, four and a half LIM 2 (FHL2) protein interacts with Forkhead box class O (FOXO1). FHL2 promotes SIRT1-mediated deacetylation of FOXO1, inhibiting its activity and promoting cancer cell survival.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cellular Signaling
Background:
- Forkhead box class O (FOXO) proteins are key transcription factors regulating apoptosis, cell cycle, and stress responses.
- FOXO proteins act downstream of the PTEN tumor suppressor pathway, crucial in cancer development.
Purpose of the Study:
- To investigate the interaction between FOXO1 and four and a half LIM 2 (FHL2) in prostate cancer cells.
- To elucidate the mechanism by which FHL2 affects FOXO1 transcriptional activity and function.
Main Methods:
- Co-immunoprecipitation to detect protein-protein interactions.
- Reporter assays to measure transcriptional activity.
- Western blotting to assess protein levels and modifications (deacetylation).
Main Results:
- FOXO1 interacts with FHL2 in the nucleus of prostate cancer cells, an interaction enhanced by lysophosphatidic acid.
- FHL2 significantly decreases FOXO1 transcriptional activity and the expression of FOXO target genes, thereby inhibiting FOXO1-induced apoptosis.
- Sirtuin-1 (SIRT1) deacetylates and inhibits FOXO1 activity; FHL2 enhances the FOXO1-SIRT1 interaction and subsequent FOXO1 deacetylation.
Conclusions:
- FHL2 inhibits FOXO1 activity in prostate cancer cells.
- This inhibition is mediated by FHL2 promoting the deacetylation of FOXO1 by SIRT1.
- The FHL2-SIRT1-FOXO1 axis represents a potential therapeutic target in prostate cancer.
Related Concept Videos
Inheritance of Chromatin Structures
Co-activators and Co-repressors
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Hedgehog Signaling Pathway
TGF - β Signaling Pathway
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

